The Anne Arundel Medical Center (AAMC) Geaton and JoAnn DeCesaris Cancer Institute has been awarded the Commission on Cancer (CoC) Outstanding Achievement Awardfor 2008 following an intensive on-site survey completed in November 2008.
The DeCesaris Cancer Institute is one of only four cancer programs in Maryland – and one of only 95 programs nationwide – to receive the prestigious award from the CoC, an organization established by the American College of Surgeons. The award was established in 1994 to recognize cancer programs demonstrating excellence in providing quality care to cancer patients. A facility receives the award only if demonstrating a “commendation” level of compliance with seven CoC-established standards of care.
AAMC demonstrated commendation-level compliance in six areas; cancer committee leadership, cancer data management, clinical services, research, community outreach, and quality improvement.
“We view this award as a true external recognition of the success of our efforts to provide comprehensive and compassionate services that span education, prevention, screening, and surgical treatment for our patients and their families,” said Barry Meisenberg, M.D., medical director of the DeCesaris Cancer Institute. “The award is truly gratifying for our staff, and should stand as an additional program differentiator for AAMC.”
Following the November 2008 on-site survey, the cancer institute was granted the highest stamp of CoC program approval: Three Year Approval with Commendation. According to the Commission, just 25 percent of all cancer centers in United States hospitals receive three-year approval, and only 14 percent of those awarded three-year approval are then awarded the additional recognition of standard of care commendations.
CoC-accredited facilities diagnose and/or treat 80 percent of newly diagnosed cancer patients each year.
“Patients receiving care at a cancer center that has been accredited by the Commission on Cancer should be reassured that they’re getting access to the most comprehensive and advanced care available,” added Cathy Copertino, R.N., M.S., O.C.N., executive director of the DeCesaris Cancer Institute. “AAMC’s patients should view this as an affirmation that our clinical staff has gone above and beyond in the delivery of cancer care.”
For more information on the AAMC DeCesaris Cancer Institute, visit http://www.aahs.org/cancer. For more information on the American College of Surgeon’s Commission on Cancer approval programs, visit http://www.facs.org/cancer/coc/approval.html.